Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction
批准号:
9912642
负责人:
JAMAL A IBDAH
金额:
$69.23万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-04-30
关键词:
Adipose tissueAftercareAnimalsBioenergeticsBiogenesisBiopsyBiopsy SpecimenBody Weight decreasedCaloric RestrictionCardiovascular DiseasesCarnitine Palmitoyltransferase ICirrhosisClinical ManagementDataDiabetes MellitusDiagnosticDiseaseEnzymesEventExerciseExhibitsFastingFatty AcidsFibrosisFunctional disorderGene ExpressionGenerationsGlucoseHepaticHistologicHistologyHumanImpairmentIn VitroIndividualInflammationInsulinInsulin ResistanceIsotopesLinkLipidsLiverLiver MitochondriaLiver diseasesLobularMagnetic Resonance SpectroscopyMeasurementMeasuresMediatingMediator of activation proteinMetabolicMethodsMitochondriaModelingMolecularMuscleNutrientObesityPathogenicityPathologicPathologyPatientsPeripheralPhasePlayPrevalencePrimary Malignant Neoplasm of LiverQuality ControlRegimenRiskRodent ModelRoleRouteSamplingSeverity of illnessStressTestingTherapeuticTherapeutic EffectTimeTissue SampleToxic effectTreatment ProtocolsTriglyceridesVO2maxWorkactive methodadvanced diseasebariatric surgerycardiorespiratory fitnessclinical careexercise trainingfatty acid oxidationglucose productionhuman dataimaging studyimprovedinsightintrahepaticlifestyle interventionlipid biosynthesisliver biopsyliver developmentliver metabolismmathematical modelmitochondrial dysfunctionmortalitynew therapeutic targetnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisoxidationresponsestandard caretheoriestreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Strong evidence from animal studies and indirect data from human imaging studies, implicate reduced
liver mitochondrial activity as a key event in the pathophysiology of nonalcoholic steatohepatitis
(NASH). Our preliminary data in NASH patients demonstrate that two treatments that relieve excess
nutrient stress, caloric restriction (CR) and exercise training (EX), improve liver histology. Our recent
studies in a rodent model established that the therapeutic effect of EX on liver histology is mediated
through increases in both hepatic mitochondrial content and function. It is unknown whether a similar
beneficial effect of such treatment on liver mitochondria occurs in humans. The central hypotheses of
this project is that nutrient overload results in hepatic mitochondrial dysfunction, a key mediator of
NASH pathology, and that amelioration of this overload will result in greater efficiency of mitochondrial
bioenergetics and improved liver histology. To test these hypotheses, a treatment regimen combining
CR and EX will be used to reduce intrahepatic triacylglycerols (IHTG) in 60 NASH patients. Baseline
and 9-month liver biopsies in the treated group will be compared to repeat biopsies from 30 patients
undergoing standard clinical management. We will complete the following specific aims. SA1 will utilize
liver biopsy samples from patients with NASH, and liver samples obtained during bariatric surgery, to
determine whether patients with more advanced liver disease have liver mitochondria that, in vitro and
ex vivo, exhibit poor energy generation (quality control), biogenesis, and mitophagy; SA2 will isolate
hepatic mitochondria again after 9-months to test whether loss of IHTG is associated with improved
mitochondrial function, biogenesis and quality control as assessed by gene expression, enzyme levels
and fatty acid oxidation. SA3 will measure whole body glucose and fatty acid flux in subjects under-
going active treatment (CR+EX) and standard care. Measures will be made at baseline and after 9
months, and mathematical modeling used to quantitate peripheral nutrient disposal and the reduction in
liver nutrient burden to compare its influence on mitochondrial function, fibrosis, and by the biopsy-
determined NASH activity score using histological assessment. In summary, these studies will
significantly advance the field of NAFLD through discoveries of 1) the mechanisms by which excess
nutrient stress contributes to reduced hepatic mitochondrial function and 2) the relationships between
mitochondrial activity and the histologic features of NASH. Importantly, this work will exert a sustained
influence on the field by determining whether hepatic mitochondrial dysfunction is reversible in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)
-
批准号:10483713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:JAMAL A IBDAH
-
依托单位:
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD
-
批准号:10516045
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JAMAL A IBDAH
-
依托单位:
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD
-
批准号:10045515
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JAMAL A IBDAH
-
依托单位:
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD
-
批准号:10292920
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JAMAL A IBDAH
-
依托单位:
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction
-
批准号:10448125
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2017
-
负责人:JAMAL A IBDAH
-
依托单位:
Nutrient overload, insulin resistance, and hepatic mitochondrial dysfunction
-
批准号:9327536
-
项目类别:
-
资助金额:$69.73万
-
财政年份:2017
-
负责人:JAMAL A IBDAH
-
依托单位:
Beta-Oxidation and Susceptibility to Fatty Liver Disease
-
批准号:7095535
-
项目类别:
-
资助金额:$27.58万
-
财政年份:2006
-
负责人:JAMAL A IBDAH
-
依托单位:
Beta-Oxidation and Susceptibility to Fatty Liver Disease
-
批准号:7261990
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2006
-
负责人:JAMAL A IBDAH
-
依托单位:
Beta-Oxidation and Susceptibility to Fatty Liver Disease
-
批准号:7484072
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2006
-
负责人:JAMAL A IBDAH
-
依托单位:
LIVER DISEASE AND FATTY OXIDATION DISORDERS
-
批准号:7203829
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2005
-
负责人:JAMAL A IBDAH
-
依托单位:
Liver Disease and Fatty Oxidation Disorders
-
批准号:7045705
-
项目类别:
-
资助金额:$2.12万
-
财政年份:2004
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:6395204
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:6643536
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:6799108
-
项目类别:
-
资助金额:$3.44万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:6941808
-
项目类别:
-
资助金额:$3.58万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:7118875
-
项目类别:
-
资助金额:$3.82万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:6760563
-
项目类别:
-
资助金额:$3.3万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:6941188
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:6524535
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
Maternal Liver Disease and Fatty Acid Oxidation Defects
-
批准号:6803202
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2001
-
负责人:JAMAL A IBDAH
-
依托单位:
海外基金